Rheumatology Network Articles

This systematic review and meta-analysis found that biologic switching was shown to be safe and effective among patients with psoriasis.

C difficile carriers had greater baseline hazard for hospital-onset infection than non-carriers, with risk not significantly affected by antibiotic exposure.

Despite obesity’s well-known influence on AF recurrence, neither comorbidity has a significant influence on outcomes from early rhythm control therapy.

FDA grants Fast Track to NRX-100, the first preservative-free IV ketamine, for treating suicidal ideation in depression.

After overcoming 2 FDA rejections, PharmaTher secures approval for ketamine (KETARX) in surgical pain.

Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key

Panelists discuss how access challenges include insurance barriers and prior authorizations for medications, while identifying key gaps in eosinophilic esophagitis

An audio recap of the top 5 stories in healthcare news from the week of 08/03-08/09.

Avacincaptad pegol, pegcetacoplan, and aflibercept 8mg do not increase risk of ocular hypertension and glaucoma, despite having higher volumes.

This summary of dermatology news coverage from the month of August 2025 highlights some of the most notable stories in